In patients with non-alcoholic steatohepatitis (NASH) and corresponding animal models, there is a notable correlation between elevated levels of the microRNA miR-21 and increased levels of caspase-2 in hepatic tissues. This evidence concerns the gene CASP2 and metabolic dysfunction-associated steatohepatitis.